Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial.
Kostis JB, Cobbe S, Johnston C, Ford I, Murphy M, Weber MA, Black HR, Plouin PF, Levy D, Mancia G, Larochelle P, Kolloch RE, Alderman M, Ruilope LM, Dahlöf B, Flack JM, Wolf R; OPERA Study Group. Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events. Kostis JB, et al. Among authors: weber ma. Am J Hypertens. 2002 Feb;15(2 Pt 1):193-8. doi: 10.1016/s0895-7061(01)02048-9. Am J Hypertens. 2002. PMID: 11863257 Clinical Trial.
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
Jamerson KA, Bakris GL, Wun CC, Dahlöf B, Lefkowitz M, Manfreda S, Pitt B, Velazquez EJ, Weber MA. Jamerson KA, et al. Among authors: weber ma. Am J Hypertens. 2004 Sep;17(9):793-801. doi: 10.1016/j.amjhyper.2004.05.004. Am J Hypertens. 2004. PMID: 15363822 Review.
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Sowers JR, Weber MA; INCLUSIVE Investigators. Neutel JM, et al. Among authors: weber ma. J Clin Hypertens (Greenwich). 2005 Oct;7(10):578-86. doi: 10.1111/j.1524-6175.2004.04720.x. J Clin Hypertens (Greenwich). 2005. PMID: 16227760 Free PMC article. Clinical Trial.
1,158 results